ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Giant Cell Arteritis Therapeutic Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-33Q14422
Home | Market Reports | Health| Health Conditions
Global Giant Cell Arteritis Therapeutic Market Research Report 2023
BUY CHAPTERS

Global Giant Cell Arteritis Therapeutic Market Research Report 2025

Code: QYRE-Auto-33Q14422
Report
May 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Regeneron
GlaxoSmithKline PLC
F Hoffmann La Roche Ltd
Novartis
AbbVie
Bristol Myers Squibb Company
Abbott
Johnson & Johnson Services Inc.
Johns Hopkins Hospital
Fortis Healthcare
American College of Rheumatology
Duke University Health System
Lahey Clinic Foundation
Kiniksa Pharmaceuticals, Ltd.

Giant Cell Arteritis Therapeutic Market

The global market for Giant Cell Arteritis Therapeutic was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Giant cell arteritis (GCA) is a granulomatous medium and large-vessel vasculitis. It is the most common form of systemic vasculitis, with an incidence of between 15 and 25 cases per 100,000 persons over 50 years of age.
North American market for Giant Cell Arteritis Therapeutic is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Giant Cell Arteritis Therapeutic is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Giant Cell Arteritis Therapeutic in Corticosteroids is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Giant Cell Arteritis Therapeutic include Sanofi, Kiniksa Pharmaceuticals, Ltd., Regeneron, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Novartis AG, AbbVie, Inc., Bristol-Myers Squibb Company, Abbott, Johnson & Johnson Services, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Giant Cell Arteritis Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Giant Cell Arteritis Therapeutic.
The Giant Cell Arteritis Therapeutic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Giant Cell Arteritis Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Giant Cell Arteritis Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Giant Cell Arteritis Therapeutic Market Report

Report Metric Details
Report Name Giant Cell Arteritis Therapeutic Market
Segment by Type
  • Prednisone
  • Methotrexate
  • Tocilizumab
  • Aspirin
Segment by Application
  • Corticosteroids
  • Immunosuppressive Agents
  • Anticoagulants
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, Kiniksa Pharmaceuticals, Ltd., Regeneron, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Novartis AG, AbbVie, Inc., Bristol-Myers Squibb Company, Abbott, Johnson & Johnson Services, Inc., Johns Hopkins Hospital, Fortis Healthcare, American College of Rheumatology, Duke University Health System, Lahey Clinic Foundation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Giant Cell Arteritis Therapeutic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Giant Cell Arteritis Therapeutic Market report?

Ans: The main players in the Giant Cell Arteritis Therapeutic Market are Sanofi, Kiniksa Pharmaceuticals, Ltd., Regeneron, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Novartis AG, AbbVie, Inc., Bristol-Myers Squibb Company, Abbott, Johnson & Johnson Services, Inc., Johns Hopkins Hospital, Fortis Healthcare, American College of Rheumatology, Duke University Health System, Lahey Clinic Foundation

What are the Application segmentation covered in the Giant Cell Arteritis Therapeutic Market report?

Ans: The Applications covered in the Giant Cell Arteritis Therapeutic Market report are Corticosteroids, Immunosuppressive Agents, Anticoagulants, Others

What are the Type segmentation covered in the Giant Cell Arteritis Therapeutic Market report?

Ans: The Types covered in the Giant Cell Arteritis Therapeutic Market report are Prednisone, Methotrexate, Tocilizumab, Aspirin

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Giant Cell Arteritis Therapeutic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Prednisone
1.2.3 Methotrexate
1.2.4 Tocilizumab
1.2.5 Aspirin
1.3 Market by Application
1.3.1 Global Giant Cell Arteritis Therapeutic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Corticosteroids
1.3.3 Immunosuppressive Agents
1.3.4 Anticoagulants
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Giant Cell Arteritis Therapeutic Market Perspective (2020-2031)
2.2 Global Giant Cell Arteritis Therapeutic Growth Trends by Region
2.2.1 Global Giant Cell Arteritis Therapeutic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Giant Cell Arteritis Therapeutic Historic Market Size by Region (2020-2025)
2.2.3 Giant Cell Arteritis Therapeutic Forecasted Market Size by Region (2026-2031)
2.3 Giant Cell Arteritis Therapeutic Market Dynamics
2.3.1 Giant Cell Arteritis Therapeutic Industry Trends
2.3.2 Giant Cell Arteritis Therapeutic Market Drivers
2.3.3 Giant Cell Arteritis Therapeutic Market Challenges
2.3.4 Giant Cell Arteritis Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Giant Cell Arteritis Therapeutic Players by Revenue
3.1.1 Global Top Giant Cell Arteritis Therapeutic Players by Revenue (2020-2025)
3.1.2 Global Giant Cell Arteritis Therapeutic Revenue Market Share by Players (2020-2025)
3.2 Global Giant Cell Arteritis Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Giant Cell Arteritis Therapeutic Revenue
3.4 Global Giant Cell Arteritis Therapeutic Market Concentration Ratio
3.4.1 Global Giant Cell Arteritis Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Giant Cell Arteritis Therapeutic Revenue in 2024
3.5 Global Key Players of Giant Cell Arteritis Therapeutic Head office and Area Served
3.6 Global Key Players of Giant Cell Arteritis Therapeutic, Product and Application
3.7 Global Key Players of Giant Cell Arteritis Therapeutic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Giant Cell Arteritis Therapeutic Breakdown Data by Type
4.1 Global Giant Cell Arteritis Therapeutic Historic Market Size by Type (2020-2025)
4.2 Global Giant Cell Arteritis Therapeutic Forecasted Market Size by Type (2026-2031)
5 Giant Cell Arteritis Therapeutic Breakdown Data by Application
5.1 Global Giant Cell Arteritis Therapeutic Historic Market Size by Application (2020-2025)
5.2 Global Giant Cell Arteritis Therapeutic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Giant Cell Arteritis Therapeutic Market Size (2020-2031)
6.2 North America Giant Cell Arteritis Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Giant Cell Arteritis Therapeutic Market Size by Country (2020-2025)
6.4 North America Giant Cell Arteritis Therapeutic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Giant Cell Arteritis Therapeutic Market Size (2020-2031)
7.2 Europe Giant Cell Arteritis Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Giant Cell Arteritis Therapeutic Market Size by Country (2020-2025)
7.4 Europe Giant Cell Arteritis Therapeutic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Giant Cell Arteritis Therapeutic Market Size (2020-2031)
8.2 Asia-Pacific Giant Cell Arteritis Therapeutic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Giant Cell Arteritis Therapeutic Market Size by Region (2020-2025)
8.4 Asia-Pacific Giant Cell Arteritis Therapeutic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Giant Cell Arteritis Therapeutic Market Size (2020-2031)
9.2 Latin America Giant Cell Arteritis Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Giant Cell Arteritis Therapeutic Market Size by Country (2020-2025)
9.4 Latin America Giant Cell Arteritis Therapeutic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Giant Cell Arteritis Therapeutic Market Size (2020-2031)
10.2 Middle East & Africa Giant Cell Arteritis Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Giant Cell Arteritis Therapeutic Market Size by Country (2020-2025)
10.4 Middle East & Africa Giant Cell Arteritis Therapeutic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Giant Cell Arteritis Therapeutic Introduction
11.1.4 Sanofi Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025)
11.1.5 Sanofi Recent Development
11.2 Kiniksa Pharmaceuticals, Ltd.
11.2.1 Kiniksa Pharmaceuticals, Ltd. Company Details
11.2.2 Kiniksa Pharmaceuticals, Ltd. Business Overview
11.2.3 Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Introduction
11.2.4 Kiniksa Pharmaceuticals, Ltd. Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025)
11.2.5 Kiniksa Pharmaceuticals, Ltd. Recent Development
11.3 Regeneron
11.3.1 Regeneron Company Details
11.3.2 Regeneron Business Overview
11.3.3 Regeneron Giant Cell Arteritis Therapeutic Introduction
11.3.4 Regeneron Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025)
11.3.5 Regeneron Recent Development
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Details
11.4.2 GlaxoSmithKline plc Business Overview
11.4.3 GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Introduction
11.4.4 GlaxoSmithKline plc Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025)
11.4.5 GlaxoSmithKline plc Recent Development
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Details
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Details
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Giant Cell Arteritis Therapeutic Introduction
11.6.4 Novartis AG Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025)
11.6.5 Novartis AG Recent Development
11.7 AbbVie, Inc.
11.7.1 AbbVie, Inc. Company Details
11.7.2 AbbVie, Inc. Business Overview
11.7.3 AbbVie, Inc. Giant Cell Arteritis Therapeutic Introduction
11.7.4 AbbVie, Inc. Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025)
11.7.5 AbbVie, Inc. Recent Development
11.8 Bristol-Myers Squibb Company
11.8.1 Bristol-Myers Squibb Company Company Details
11.8.2 Bristol-Myers Squibb Company Business Overview
11.8.3 Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Introduction
11.8.4 Bristol-Myers Squibb Company Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025)
11.8.5 Bristol-Myers Squibb Company Recent Development
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Abbott Business Overview
11.9.3 Abbott Giant Cell Arteritis Therapeutic Introduction
11.9.4 Abbott Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025)
11.9.5 Abbott Recent Development
11.10 Johnson & Johnson Services, Inc.
11.10.1 Johnson & Johnson Services, Inc. Company Details
11.10.2 Johnson & Johnson Services, Inc. Business Overview
11.10.3 Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Introduction
11.10.4 Johnson & Johnson Services, Inc. Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025)
11.10.5 Johnson & Johnson Services, Inc. Recent Development
11.11 Johns Hopkins Hospital
11.11.1 Johns Hopkins Hospital Company Details
11.11.2 Johns Hopkins Hospital Business Overview
11.11.3 Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Introduction
11.11.4 Johns Hopkins Hospital Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025)
11.11.5 Johns Hopkins Hospital Recent Development
11.12 Fortis Healthcare
11.12.1 Fortis Healthcare Company Details
11.12.2 Fortis Healthcare Business Overview
11.12.3 Fortis Healthcare Giant Cell Arteritis Therapeutic Introduction
11.12.4 Fortis Healthcare Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025)
11.12.5 Fortis Healthcare Recent Development
11.13 American College of Rheumatology
11.13.1 American College of Rheumatology Company Details
11.13.2 American College of Rheumatology Business Overview
11.13.3 American College of Rheumatology Giant Cell Arteritis Therapeutic Introduction
11.13.4 American College of Rheumatology Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025)
11.13.5 American College of Rheumatology Recent Development
11.14 Duke University Health System
11.14.1 Duke University Health System Company Details
11.14.2 Duke University Health System Business Overview
11.14.3 Duke University Health System Giant Cell Arteritis Therapeutic Introduction
11.14.4 Duke University Health System Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025)
11.14.5 Duke University Health System Recent Development
11.15 Lahey Clinic Foundation
11.15.1 Lahey Clinic Foundation Company Details
11.15.2 Lahey Clinic Foundation Business Overview
11.15.3 Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Introduction
11.15.4 Lahey Clinic Foundation Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025)
11.15.5 Lahey Clinic Foundation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Sanofi
Regeneron
GlaxoSmithKline PLC
F Hoffmann La Roche Ltd
Novartis
AbbVie
Bristol Myers Squibb Company
Abbott
Johnson & Johnson Services Inc.
Johns Hopkins Hospital
Fortis Healthcare
American College of Rheumatology
Duke University Health System
Lahey Clinic Foundation
Kiniksa Pharmaceuticals, Ltd.
List of Tables
 Table 1. Global Giant Cell Arteritis Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Prednisone
 Table 3. Key Players of Methotrexate
 Table 4. Key Players of Tocilizumab
 Table 5. Key Players of Aspirin
 Table 6. Global Giant Cell Arteritis Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Giant Cell Arteritis Therapeutic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Giant Cell Arteritis Therapeutic Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Giant Cell Arteritis Therapeutic Market Share by Region (2020-2025)
 Table 10. Global Giant Cell Arteritis Therapeutic Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Giant Cell Arteritis Therapeutic Market Share by Region (2026-2031)
 Table 12. Giant Cell Arteritis Therapeutic Market Trends
 Table 13. Giant Cell Arteritis Therapeutic Market Drivers
 Table 14. Giant Cell Arteritis Therapeutic Market Challenges
 Table 15. Giant Cell Arteritis Therapeutic Market Restraints
 Table 16. Global Giant Cell Arteritis Therapeutic Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Giant Cell Arteritis Therapeutic Market Share by Players (2020-2025)
 Table 18. Global Top Giant Cell Arteritis Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Giant Cell Arteritis Therapeutic as of 2024)
 Table 19. Ranking of Global Top Giant Cell Arteritis Therapeutic Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Giant Cell Arteritis Therapeutic Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Giant Cell Arteritis Therapeutic, Headquarters and Area Served
 Table 22. Global Key Players of Giant Cell Arteritis Therapeutic, Product and Application
 Table 23. Global Key Players of Giant Cell Arteritis Therapeutic, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Giant Cell Arteritis Therapeutic Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Giant Cell Arteritis Therapeutic Revenue Market Share by Type (2020-2025)
 Table 27. Global Giant Cell Arteritis Therapeutic Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Giant Cell Arteritis Therapeutic Revenue Market Share by Type (2026-2031)
 Table 29. Global Giant Cell Arteritis Therapeutic Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Giant Cell Arteritis Therapeutic Revenue Market Share by Application (2020-2025)
 Table 31. Global Giant Cell Arteritis Therapeutic Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Giant Cell Arteritis Therapeutic Revenue Market Share by Application (2026-2031)
 Table 33. North America Giant Cell Arteritis Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Giant Cell Arteritis Therapeutic Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Giant Cell Arteritis Therapeutic Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Giant Cell Arteritis Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Giant Cell Arteritis Therapeutic Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Giant Cell Arteritis Therapeutic Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Giant Cell Arteritis Therapeutic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Giant Cell Arteritis Therapeutic Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Giant Cell Arteritis Therapeutic Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Giant Cell Arteritis Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Giant Cell Arteritis Therapeutic Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Giant Cell Arteritis Therapeutic Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Sanofi Company Details
 Table 49. Sanofi Business Overview
 Table 50. Sanofi Giant Cell Arteritis Therapeutic Product
 Table 51. Sanofi Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025) & (US$ Million)
 Table 52. Sanofi Recent Development
 Table 53. Kiniksa Pharmaceuticals, Ltd. Company Details
 Table 54. Kiniksa Pharmaceuticals, Ltd. Business Overview
 Table 55. Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Product
 Table 56. Kiniksa Pharmaceuticals, Ltd. Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025) & (US$ Million)
 Table 57. Kiniksa Pharmaceuticals, Ltd. Recent Development
 Table 58. Regeneron Company Details
 Table 59. Regeneron Business Overview
 Table 60. Regeneron Giant Cell Arteritis Therapeutic Product
 Table 61. Regeneron Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025) & (US$ Million)
 Table 62. Regeneron Recent Development
 Table 63. GlaxoSmithKline plc Company Details
 Table 64. GlaxoSmithKline plc Business Overview
 Table 65. GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Product
 Table 66. GlaxoSmithKline plc Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025) & (US$ Million)
 Table 67. GlaxoSmithKline plc Recent Development
 Table 68. F. Hoffmann-La Roche Ltd. Company Details
 Table 69. F. Hoffmann-La Roche Ltd. Business Overview
 Table 70. F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Product
 Table 71. F. Hoffmann-La Roche Ltd. Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025) & (US$ Million)
 Table 72. F. Hoffmann-La Roche Ltd. Recent Development
 Table 73. Novartis AG Company Details
 Table 74. Novartis AG Business Overview
 Table 75. Novartis AG Giant Cell Arteritis Therapeutic Product
 Table 76. Novartis AG Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025) & (US$ Million)
 Table 77. Novartis AG Recent Development
 Table 78. AbbVie, Inc. Company Details
 Table 79. AbbVie, Inc. Business Overview
 Table 80. AbbVie, Inc. Giant Cell Arteritis Therapeutic Product
 Table 81. AbbVie, Inc. Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025) & (US$ Million)
 Table 82. AbbVie, Inc. Recent Development
 Table 83. Bristol-Myers Squibb Company Company Details
 Table 84. Bristol-Myers Squibb Company Business Overview
 Table 85. Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Product
 Table 86. Bristol-Myers Squibb Company Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025) & (US$ Million)
 Table 87. Bristol-Myers Squibb Company Recent Development
 Table 88. Abbott Company Details
 Table 89. Abbott Business Overview
 Table 90. Abbott Giant Cell Arteritis Therapeutic Product
 Table 91. Abbott Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025) & (US$ Million)
 Table 92. Abbott Recent Development
 Table 93. Johnson & Johnson Services, Inc. Company Details
 Table 94. Johnson & Johnson Services, Inc. Business Overview
 Table 95. Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Product
 Table 96. Johnson & Johnson Services, Inc. Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025) & (US$ Million)
 Table 97. Johnson & Johnson Services, Inc. Recent Development
 Table 98. Johns Hopkins Hospital Company Details
 Table 99. Johns Hopkins Hospital Business Overview
 Table 100. Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Product
 Table 101. Johns Hopkins Hospital Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025) & (US$ Million)
 Table 102. Johns Hopkins Hospital Recent Development
 Table 103. Fortis Healthcare Company Details
 Table 104. Fortis Healthcare Business Overview
 Table 105. Fortis Healthcare Giant Cell Arteritis Therapeutic Product
 Table 106. Fortis Healthcare Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025) & (US$ Million)
 Table 107. Fortis Healthcare Recent Development
 Table 108. American College of Rheumatology Company Details
 Table 109. American College of Rheumatology Business Overview
 Table 110. American College of Rheumatology Giant Cell Arteritis Therapeutic Product
 Table 111. American College of Rheumatology Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025) & (US$ Million)
 Table 112. American College of Rheumatology Recent Development
 Table 113. Duke University Health System Company Details
 Table 114. Duke University Health System Business Overview
 Table 115. Duke University Health System Giant Cell Arteritis Therapeutic Product
 Table 116. Duke University Health System Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025) & (US$ Million)
 Table 117. Duke University Health System Recent Development
 Table 118. Lahey Clinic Foundation Company Details
 Table 119. Lahey Clinic Foundation Business Overview
 Table 120. Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Product
 Table 121. Lahey Clinic Foundation Revenue in Giant Cell Arteritis Therapeutic Business (2020-2025) & (US$ Million)
 Table 122. Lahey Clinic Foundation Recent Development
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Giant Cell Arteritis Therapeutic Picture
 Figure 2. Global Giant Cell Arteritis Therapeutic Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Giant Cell Arteritis Therapeutic Market Share by Type: 2024 VS 2031
 Figure 4. Prednisone Features
 Figure 5. Methotrexate Features
 Figure 6. Tocilizumab Features
 Figure 7. Aspirin Features
 Figure 8. Global Giant Cell Arteritis Therapeutic Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Giant Cell Arteritis Therapeutic Market Share by Application: 2024 VS 2031
 Figure 10. Corticosteroids Case Studies
 Figure 11. Immunosuppressive Agents Case Studies
 Figure 12. Anticoagulants Case Studies
 Figure 13. Others Case Studies
 Figure 14. Giant Cell Arteritis Therapeutic Report Years Considered
 Figure 15. Global Giant Cell Arteritis Therapeutic Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Giant Cell Arteritis Therapeutic Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Giant Cell Arteritis Therapeutic Market Share by Region: 2024 VS 2031
 Figure 18. Global Giant Cell Arteritis Therapeutic Market Share by Players in 2024
 Figure 19. Global Top Giant Cell Arteritis Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Giant Cell Arteritis Therapeutic as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Giant Cell Arteritis Therapeutic Revenue in 2024
 Figure 21. North America Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Giant Cell Arteritis Therapeutic Market Share by Country (2020-2031)
 Figure 23. United States Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Giant Cell Arteritis Therapeutic Market Share by Country (2020-2031)
 Figure 27. Germany Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Giant Cell Arteritis Therapeutic Market Share by Region (2020-2031)
 Figure 35. China Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Giant Cell Arteritis Therapeutic Market Share by Country (2020-2031)
 Figure 43. Mexico Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Giant Cell Arteritis Therapeutic Market Share by Country (2020-2031)
 Figure 47. Turkey Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Giant Cell Arteritis Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Sanofi Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2020-2025)
 Figure 51. Kiniksa Pharmaceuticals, Ltd. Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2020-2025)
 Figure 52. Regeneron Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2020-2025)
 Figure 53. GlaxoSmithKline plc Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2020-2025)
 Figure 54. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2020-2025)
 Figure 55. Novartis AG Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2020-2025)
 Figure 56. AbbVie, Inc. Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2020-2025)
 Figure 57. Bristol-Myers Squibb Company Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2020-2025)
 Figure 58. Abbott Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2020-2025)
 Figure 59. Johnson & Johnson Services, Inc. Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2020-2025)
 Figure 60. Johns Hopkins Hospital Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2020-2025)
 Figure 61. Fortis Healthcare Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2020-2025)
 Figure 62. American College of Rheumatology Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2020-2025)
 Figure 63. Duke University Health System Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2020-2025)
 Figure 64. Lahey Clinic Foundation Revenue Growth Rate in Giant Cell Arteritis Therapeutic Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Giant Cell Arteritis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Eosinophilic Granulomatosis with Polyangiitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Granulomatosis with Polyangiitis Drug Market Research Report 2025
Global Retinal Vasculitis Treatment Market Research Report 2025
Global Arteriosclerosis Therapeutics Market Insights Forecast to 2030
Chronic Granulomatous Disease CGD Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microscopic Polyangiitis MPA Treatment Market Research Report 2025
Global IgA Nephropathy Drugs Market Research Report 2025
Global Coronary Artery Disease Therapeutics Market Research Report 2024
Global Geographic Atrophy Drugs Market Research Report 2024
Global Geographic Atrophy Market Research Report 2025
Geographic Atrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gadolinium Contrast Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Myocardial Fibrosis Market Insights Forecast to 2030
Temporal Arteritis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tenosynovial Giant Cell Tumor Treatment Market Research Report 2025
Global Chronic Granulomatous Disease CGD Management Market Research Report 2024
Global Aneurysm Therapeutics Market Insights Forecast to 2030
Eosinophilic Granulomatosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Aortic Aneurysm Market

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Z7671
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10V14317
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O5919
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I19963
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions